80 Participants Needed

Opioid-Free Approach for Postoperative Pain

Recruiting at 2 trial locations
AD
Overseen ByAlexander Dawes
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this investigation is to compare effectiveness of this multimodal regimen at controlling postoperative pain with and without the use of opioid medications.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it excludes those who have used opioids in the last 3 months. It's best to discuss your specific medications with the trial team.

What data supports the effectiveness of the Opioid-Free Orthopaedics treatment for postoperative pain?

Research shows that using a combination of different pain relief methods, known as multimodal pain management, can effectively reduce pain and the need for opioids after surgery. This approach has been successful in major joint replacement surgeries and shoulder surgeries, leading to better recovery and high patient satisfaction.12345

Is opioid-free pain management safe for postoperative care?

Research shows that opioid-free pain management strategies, like multimodal analgesia, are generally safe for postoperative care, with minimal side effects and without compromising patient satisfaction.23567

How is the Opioid-Free Orthopaedics treatment different from other treatments for postoperative pain?

The Opioid-Free Orthopaedics treatment is unique because it uses a multimodal approach, combining various non-opioid medications and techniques to manage pain, which reduces the need for opioids and their associated risks. This approach is personalized to the patient's needs and can include options like physical therapy, exercise, and nutritional counseling, making it a safer and more comprehensive alternative to traditional opioid-based pain management.12347

Research Team

Dr. Eric R Wagner, MD, MSc - Atlanta ...

Eric Wagner, MD, MS

Principal Investigator

Emory University

Eligibility Criteria

This trial is for adults over 18 with advanced arthritis needing joint replacement or orthopaedic surgery on limbs, who have tried nonoperative treatments. Excluded are pregnant women, minors, those unwilling to consent, patients with recent opioid use, significant other injuries or conditions like uncontrolled diabetes or liver/renal disease.

Inclusion Criteria

I am having surgery on my finger, hand, wrist, forearm, or elbow.
I am having a joint replacement due to severe arthritis.
I've tried non-surgical treatments like rest, injections, and physical therapy for over 3 months.
See 2 more

Exclusion Criteria

Before joining the study, you will have blood tests to check how well your kidneys and liver are working.
I do not have major injuries, infections, substance abuse issues, recent opioid use, severe kidney or liver disease, issues with nerve blocks, uncontrolled diabetes (HbA1C >9.0), or conditions preventing the use of Aspirin.
Workman's compensation status, minors, vulnerable subjects, women who are pregnant, or those who are not willing to consent to participate in the study
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either encapsulated opioids or placebo as part of a multimodal pain control regimen after orthopedic surgery

6 weeks
Multiple visits for pain assessment and monitoring

Follow-up

Participants are monitored for safety, effectiveness, and complications after treatment

60 months
Follow-up visits at 6 weeks, 3 months, 6 months, 12 months, 24 months, and 60 months

Treatment Details

Interventions

  • Opioid-Free Orthopaedics
Trial OverviewThe study compares the effectiveness of a multimodal pain control regimen with and without opioids in managing post-surgery pain. Participants will receive either Oxycodone tablets or placebo pills after their orthopaedic procedures.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Placebo GroupExperimental Treatment1 Intervention
Participants will receive encapsulated placebo tablets x24, to take po q6 hours as need for pain after surgery "Safety" Prescription: Oxycodone5 mg po q6 hours as needed for pain
Group II: Opioid GroupActive Control1 Intervention
Participants will receive encapsulated Oxycodone 5 mg tablets x24, to take po q6 hours as needed after surgery Safety" Prescription: Oxycodone5 mg po q6 hours as needed for pain

Opioid-Free Orthopaedics is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Multimodal Pain Management for:
  • Postoperative pain management in orthopaedic surgery
🇪🇺
Approved in European Union as Non-Opioid Orthopaedic Pain Management for:
  • Postoperative pain management in orthopaedic procedures

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

Findings from Research

A multimodal analgesic approach, which combines various pain relief methods, is effective in improving postoperative pain management and reducing the need for opioids, but its implementation is not consistent across all practices.
An optimal regimen should include acetaminophen, non-steroidal anti-inflammatory drugs, dexamethasone, and regional analgesic techniques, while also considering patient education and non-pharmacological interventions, especially for those at high risk for postoperative pain.
Rational Multimodal Analgesia for Perioperative Pain Management.Joshi, GP.[2023]
A nonopioid multimodal analgesia protocol can effectively reduce pain and the need for opioids after common sports medicine procedures, promoting safer pain management.
This approach minimizes side effects and maintains patient satisfaction, suggesting it is a viable alternative to traditional opioid prescriptions.
Editorial Commentary: Opioids After Orthopaedic Surgery: Who Needs 'Em?Kluczynski, MA.[2020]
A new opioid-free pain management pathway for shoulder arthroplasty significantly reduced pain levels compared to a traditional opioid-containing pathway, with lower median pain ratings at 12 hours, 24 hours, and 2 weeks post-surgery.
The opioid-free group required much less opioid medication overall (20 mg vs. 4936.25 mg in the opioid group) and reported no readmissions or significant side effects, indicating that this approach is both safe and effective.
Opioid-free shoulder arthroplasty is safe, effective, and predictable compared with a traditional perioperative opiate regimen: a randomized controlled trial of a new clinical care pathway.Jolissaint, JE., Scarola, GT., Odum, SM., et al.[2022]

References

Rational Multimodal Analgesia for Perioperative Pain Management. [2023]
Editorial Commentary: Opioids After Orthopaedic Surgery: Who Needs 'Em? [2020]
Opioid-free shoulder arthroplasty is safe, effective, and predictable compared with a traditional perioperative opiate regimen: a randomized controlled trial of a new clinical care pathway. [2022]
Multimodal Pain Management for Major Joint Replacement Surgery. [2020]
Opioid-Sparing Pain Management in Upper Extremity Surgery: Part 1: Role of the Surgeon and Anesthesiologist. [2020]
Opioid-Sparing Pain Management in Upper Extremity Surgery: Part 2: Surgeon as Prescriber. [2020]
Non-Opioid Perioperative Pain Strategies for the Clinician: A Narrative Review. [2021]